-transparent.png){kind=logo}
Experimental and clinical data suggests that increased serum catecholamines may have predominantly detrimental effects in patients with congestive heart failure. Some investigators have proposed use of beta-blockers in heart failure as a means of ameliorating the harmful effects of the excess catecholamines. The clinical experience to date with use of these agents as therapy in congestive heart failure is limited but does suggest a future role for beta-blockers as adjunct therapy in a select population of patients with heart failure.
Related Publications
S Charlap, and
E Lichstein, and
W H Frishman
January 1986,
Henry Ford Hospital medical journal,
S Charlap, and
E Lichstein, and
W H Frishman
November 1990,
Clinical pharmacy,
S Charlap, and
E Lichstein, and
W H Frishman
January 2002,
Reviews in cardiovascular medicine,
S Charlap, and
E Lichstein, and
W H Frishman
September 2008,
Journal of the American College of Cardiology,
S Charlap, and
E Lichstein, and
W H Frishman
January 1997,
Annual review of medicine,
S Charlap, and
E Lichstein, and
W H Frishman
November 1993,
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
S Charlap, and
E Lichstein, and
W H Frishman
June 2000,
The West Indian medical journal,
S Charlap, and
E Lichstein, and
W H Frishman
December 1995,
European heart journal,
S Charlap, and
E Lichstein, and
W H Frishman
January 1983,
The Indian journal of chest diseases & allied sciences,
S Charlap, and
E Lichstein, and
W H Frishman
October 2000,
Arquivos brasileiros de cardiologia,
